GlaxoSmithKline has awarded its GBP1.1 billion global media buying and planning business to incumbent agencies PHD and MediaCom after a competitive pitch. The global account includes the former Novartis vaccine business, which GSK bought from its rival pharma company in March as part of a wider deal.